VERA
Income statement / Annual
Last year (2023), Vera Therapeutics, Inc.'s total revenue was $1.86 M,
and the percentage change from the previous year is not available.
In 2023, Vera Therapeutics, Inc.'s net income was -$95.99 M.
See Vera Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$1.86 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$0.00 |
-$846,000.00 |
$176,000.00 |
$251,000.00 |
$509,000.00 |
| Gross Profit |
$1.86 M |
$846,000.00 |
-$176,000.00 |
-$251,000.00 |
-$509,000.00 |
| Gross Profit Ratio |
1 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$78.23 M
|
$68.99 M
|
$22.48 M
|
$45.21 M
|
$7.29 M
|
| General & Administrative
Expenses |
$23.79 M
|
$21.91 M
|
$11.92 M
|
$4.04 M
|
$4.41 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$23.79 M
|
$21.91 M
|
$11.92 M
|
$4.04 M
|
$4.41 M
|
| Other Expenses |
$0.00 |
$1.85 M |
$1.79 M |
-$1.08 M |
$0.00 |
| Operating Expenses |
$102.01 M |
$90.90 M |
$34.40 M |
$49.25 M |
$11.70 M |
| Cost And Expenses |
$102.01 M |
$90.90 M |
$34.40 M |
$49.25 M |
$11.70 M |
| Interest Income |
$4.19 M |
$1.75 M |
$15,000.00 |
$8,000.00 |
$159,000.00 |
| Interest Expense |
$0.00 |
$992,000.00 |
$20,000.00 |
$166,000.00 |
$51,000.00 |
| Depreciation &
Amortization |
$0.00
|
-$846,000.00
|
$176,000.00
|
$251,000.00
|
$509,000.00
|
| EBITDA |
-$102.01 M
|
-$90.90 M
|
-$34.23 M
|
-$53.00 M
|
-$11.19 M
|
| EBITDA Ratio |
-54.79 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
-54.79
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$6.02 M
|
$1.85 M
|
$1.79 M
|
-$1.17 M
|
$108,000.00
|
| Income Before Tax |
-$95.99 M |
-$89.06 M |
-$32.61 M |
-$53.41 M |
-$11.85 M |
| Income Before Tax Ratio
|
-51.55
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$1,000.00 |
$1,000.00 |
$1,000.00 |
$1,000.00 |
$1,000.00 |
| Net Income |
-$95.99 M |
-$89.06 M |
-$32.61 M |
-$53.41 M |
-$11.85 M |
| Net Income Ratio |
-51.55 |
0 |
0 |
0 |
0 |
| EPS |
-2.25 |
-3.35 |
-1.53 |
-14.4 |
-3.46 |
| EPS Diluted |
-2.25 |
-3.35 |
-1.53 |
-14.4 |
-3.46 |
| Weighted Average Shares
Out |
$42.71 M
|
$26.57 M
|
$21.28 M
|
$3.71 M
|
$3.42 M
|
| Weighted Average Shares
Out Diluted |
$42.71 M
|
$26.57 M
|
$21.28 M
|
$3.71 M
|
$3.42 M
|
| Link |
|
|
|
|
|
